Diagnosing WD requires a high index of suspicion; the mean delay from symptoms to diagnosis has been reported to be 2 years (range: 0.08 -30 years) 3 . Our patient had no symptoms and only presented with an elevated ALT, despite the lowering of his HBV-DNA. Quantitation of hepatic copper by liver biopsy can be very useful, with hepatic copper >250 µg/g dry weight providing a sensitivity of 83.3% and a specificity of 98.6%, while values <75 µg/g exclude the diagnosis 4 . However, levels between 75 and 250 µg/g are inconclusive. Moreover, liver biopsy is an invasive procedure.
In our experience, genetic analysis of ATP7B remains the most decisive and non-invasive diagnostic tool, with a mutation detection rate of 97.6% 5 The two disease-causing mutations of our patient p.Pro868fs and p.Asp1047val, are known mutations found in Hong Kong Chinese WD patients.
Since both CHB and WD are common in East Asian populations, one should be vigilant for other causes of elevated ALT levels in patients with known CHB. While traditional biochemical markers like serum ceruloplasmin and 24-hour urine copper should always be used as first-line investigations, they should be supplemented with molecular genetic studies in case of diagnostic difficulties. With WD more common than traditionally perceived, mutational analysis has the potential to be applied at a broader basis before symptoms occur.
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